Counter screening of hybridoma clones by indirect ELISA for performance using a provided compound (i.e., drug or endogenous protein). This charge applies to any or all phases of clonal selection.
产品描述
该COUNTER SCREENING (cost per compound, any/all phases) - MAB-079的详细信息查看Rockland提供的产品说明书
产品形式
该COUNTER SCREENING (cost per compound, any/all phases) - MAB-079的详细信息查看Rockland提供的产品说明书
保存建议
该COUNTER SCREENING (cost per compound, any/all phases) - MAB-079的详细信息查看Rockland提供的产品说明书